Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Items 801–900 of 1,000
Tchao, J., Kim, J. J., Lin, B., Salama, G., Lo, C. W. Y., Yang, L., & Tobita, K. (2013) · International Journal of Tissue Engineering · doi:10.1155/2013/198762 · Cited by 17
“iPS cells were maintained on mouse embryonic fibroblast (MEF) feeder layers with regular human embryonic stem cell medium containing 10 ng/mL FGF-2 [9].”
BackgroundMethodInfluentialSelf-citationHuman cardiomyogenesis and the need for systems biology analysis
Young, D. A., DeQuach, J. A., & Christman, K. L. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.141 · Cited by 18
Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy
Ichimura, H., & Shiba, Y. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0400 · Cited by 17
Proteomic-based approaches to cardiac development and disease
Dorr, K. M., & Conlon, F. L. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.01.001 · Cited by 17
Human embryonic stem cells and cardiac cell fate
Nury, D., Néri, T., & Pucéat, M. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21631 · Cited by 17
Cell Therapy for Heart Disease
Heldman, A. W., Zambrano, J. P., & Hare, J. M. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.028 · Cited by 17
Advances in Manufacturing Cardiomyocytes from Human Pluripotent Stem Cells
Floy, M. E., Shabnam, F., Simmons, A. D., Bhute, V. J., Jin, G., Friedrich, W. A., Steinberg, A. B., & Palecek, S. P. (2022) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-092120-033922 · Cited by 18
Ptk7 Marks the First Human Developmental EMT In Vitro
Chan, D. N., Azghadi, S. F., Feng, J., & Lowry, W. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050432 · Cited by 18
Cardiac Repair and Restoration Using Human Embryonic Stem Cells
Bernstein, H. S. (2012) · Regenerative Medicine · doi:10.2217/rme.12.46 · Cited by 17
Shabani, P., Ghazizadeh, Z., Gorgani‐Firuzjaee, S., Molazem, M., Rajabi, S., Vahdat, S., Azizi, Y., Doosti, M., Aghdami, N., & Baharvand, H. (2019) · BioFactors · doi:10.1002/biof.1501 · Cited by 16
Pluripotency and Growth Factors in Early Embryonic Development of Mammals: A Comparative Approach
Llobat, L. (2021) · Veterinary Sciences · doi:10.3390/vetsci8050078 · Cited by 19
“In human and mouse embryos, FGF promotes mesoderm formation and proliferation [84,85].”
BackgroundRat full term amniotic fluid harbors highly potent stem cells
Mun-Fun, H., Ferdaos, N., Hamzah, S. N., Ridzuan, N., Hisham, N. A., Abdullah, S., Ramasamy, R., Cheah, P.-S., Thilakavathy, K., Yazid, M. N., et al. (2015) · Research in Veterinary Science · doi:10.1016/j.rvsc.2015.07.010 · Cited by 16
Adler, E., Chen, V. C., Bystrup, A., Kaplan, A. D., Giovannone, S., Eriley-Saebo, K., Young, W., Kattman, S., Mani, V., Laflamme, M. A., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-135426 · Cited by 16
“The recent development of robust protocols for the generation of cardiomyocytes from both mouse and human ESCs provides, for the first time, a source of these cells for transplantation studies (10, 11).”
BackgroundSelf-citationCardiac regeneration: different cells same goal
Barnett, P., & van den Hoff, M. J. B. (2011) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-011-0776-5 · Cited by 19
“Later Yang and co-workers adapted and improved this protocol by including a later phase of WNT inhibition via DKK (dikkopf homologue 1) and VEGF (vascular endothelial growth factor) treatment [86].”
BackgroundCell-Cycle-Based Strategies to Drive Myocardial Repair
Zhu, W., Hassink, R. J., Rubart, M., & Field, L. J. (2009) · Pediatric Cardiology · doi:10.1007/s00246-009-9408-3 · Cited by 16
“The ability to isolate and engraft cardiomyogenic precursors from human embryonic stem cells [25] as well as other cardiomyogenic precursors will greatly facilitate such analyses.”
BackgroundSelf-citationSorting cardiomyocytes: a simple solution after all?
Mummery, C. L. (2009) · Nature Methods · doi:10.1038/nmeth0110-40 · Cited by 16
Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope?
Feng, Y., Wang, Y., Cao, N., Yang, H., & Wang, Y. (2012) · PubMed · doi:10.3978/j.issn.2224-5820.2012.04.01 · Cited by 17
Generation of induced cardiac progenitor cellsviasomatic reprogramming
Xu, J., Lian, W., Li, L., & Huang, Z. W. (2017) · Oncotarget · doi:10.18632/oncotarget.15272 · Cited by 16
“Whole genome expression analysis showed that they are similar with ESC derived CPCs. Transplanting Flk1+PdgfR⍺+ iCPC into MI mice model improved heart function [129].”
BackgroundMethodInfluentialGuided differentiation and tissue regeneration of induced pluripotent stem cells using biomaterials
Kuo, Y., & Rajesh, R. (2017) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2017.04.043 · Cited by 16
Cui, C., Geng, L., Shi, J., Zhu, Y., Yang, G., Wang, Z., Wang, J., & Chen, M. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0566-6 · Cited by 16
“It is widely acknowledged that newly differentiated cardiomyocytes are in a foetal state with immature structural and electrophysiological properties [37].”
Sahara, M., Hansson, E. M., Wernet, O., Lui, K. O., Später, D., & Chien, K. R. (2015) · Cell Research · doi:10.1038/cr.2015.2 · Cited by 16
Hao, T., Li, J., Yao, F., Dong, D., Wang, Y., Yang, B., & Wang, C. (2018) · ACS Nano · doi:10.1021/acsnano.8b06561 · Cited by 16
Platform-agnostic CellNet enables cross-study analysis of cell fate engineering protocols
Lo, E. K. W., Velazquez, J. J., Peng, D., Kwon, C., Ebrahimkhani, M. R., & Cahan, P. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.06.008 · Cited by 15
Bannerman, D., Pascual‐Gil, S., Campbell, S., Jiang, R., Wu, Q., Okhovatian, S., Wagner, K. T., Montgomery, M., Laflamme, M. A., Huyer, L. D., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100917 · Cited by 16
Farboud, S. P., Fathi, E., Valipour, B., & Farahzadi, R. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05499-8 · Cited by 18
“These populations derived from the KDR low /C-KIT neg give rise to colonies that contain three lineages (CMs, endothelial cells and vascular smooth muscle cells) when plated in methyl cellulose cultures [28].”
BackgroundCardiomyocyte Differentiation from Human Embryonic Stem Cells
Mazzotta, S., Lynch, A. T., & Hoppler, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8597-5_5 · Cited by 15
Therapeutic Potential of Pluripotent Stem Cells for Cardiac Repair after Myocardial Infarction
Okano, S., & Shiba, Y. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00257 · Cited by 15
Sobral-Reyes, M. F., & Lemos, D. R. (2019) · Stem Cells · doi:10.1002/stem.3131 · Cited by 15
Darche, F. F., Ullrich, N. D., Huang, Z., Koenen, M., Rivinius, R., Frey, N., & Schweizer, P. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137318 · Cited by 17
“They consisted of the induction of mesoderm formation using either Wnt activation by CHIR99021, a small molecule inhibiting glycogen synthase kinase (GSK3) [15,16] or activation of the bone morphogenetic protein (BMP) and ACTIVIN A pathways [11,12,21].”
MethodTargeting cardiac potassium channels for state-of-the-art drug discovery
Walsh, K. B. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.983471 · Cited by 16
“Subsequently, several teams of investigators reported the generation and differentiation of human iPSC-derived cardiomyocytes (iPSC-CMs) [40-42].”
BackgroundViral and non-viral gene delivery and its role in pluripotent stem cell engineering
Kane, N. M., McRae, S., Denning, C. N., & Baker, A. H. (2008) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2008.10.002 · Cited by 15
Moon, S., Ban, K., Kim, C., Kim, S.-S., Byun, J., Song, M.-K., Park, I., Yu, S. P., & Yoon, Y. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.077 · Cited by 15
“Several independent groups have successfully generated CMs from human PSCs [14–19].”
BackgroundMethodInfluentialPluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease.
Chao, T., Chen, I., Tseng, S.-Y., & Li, Y. (2014) · PubMed · Cited by 15
Effects of 3‐D microwell culture on initial fate specification in human embryonic stem cells
Hsiao, C., Tomai, M., Glynn, J. J., & Palecek, S. P. (2014) · AIChE Journal · doi:10.1002/aic.14351 · Cited by 16
Outten, J. T., Cheng, X., Gadue, P. J., French, D. L., & Diamond, S. L. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.11.001 · Cited by 18
“KDR has frequently been utilized to characterize early mesoderm prior to diverging to a KDR+ lateral lineage or a PDGFRα+ paraxial lineage (Nostro et al., 2008; Sakurai et al., 2006) and is also expressed at low levels by hESCs (Yang et al., 2008).”
BackgroundMethodResultInfluentialHirose, S., Makiyama, T., Melgari, D., Yamamoto, Y., Wuriyanghai, Y., Yokoi, F., Nishiuchi, S., Harita, T., Hayano, M., Kohjitani, H., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00761 · Cited by 17
“Cardiomyocyte differentiation was induced with an embryoid body (EB) differentiation system as previously described (Yang et al., 2008; Wuriyanghai et al., 2018).”
MethodKawaguchi, N., & Nakanishi, T. (2013) · Cells · doi:10.3390/cells2010067 · Cited by 15
Matsuda, T., Miyagawa, S., Fukushima, S., Kitagawa‐Sakakida, S., Akimaru, H., Horii, M., Kawamoto, A., Saito, A., Asahara, T., & Sawa, Y. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0534 · Cited by 15
Recent advancements of human iPSC derived cardiomyocytes in drug screening and tissue regeneration
Huang, Y., Wang, T., Lopez, M. E. U., Hirano, M., Hasan, A., & Shin, S. R. (2020) · Microphysiological Systems · doi:10.21037/mps-20-3 · Cited by 14
“The combination of activin A and BMP-4 in a serum-free monolayer medium has generated a total of over 50% of contracting CMs (33).”
BackgroundKim, J. H., Oh, A., Choi, Y. M., Ku, S., Kim, Y. Y., LEE, N. J., Šepac, A., & Bosnjak, Z. J. (2011) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2011.02509.x · Cited by 14
Ng, K., Chan, Y.-C., Lee, Y.-K., Lai, W., Au, K., Fung, M., Siu, C., Li, R. A., & Tse, H. (2011) · Cellular Reprogramming · doi:10.1089/cell.2011.0038 · Cited by 15
“After suspension, EBs were plated onto a gelatin-coated plate in a basal medium [StemPro34, Invitrogen, containing 2 mM glutamine, 4 mM monothioglycerol (MTG), 50 lg/mL ascorbic acid, and 0.5 ng/mL bone morphogenetic protein-4 [BMP4]) according to previous protocol (Yang et al., 2008).”
BackgroundMethodInfluentialZhang, K., Deacon, D. C., Rao, F., Schork, A. J., Fung, M. M., Waalen, J., Schork, N. J., Nievergelt, C. M., Chi, N. C., & O’Connor, D. T. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.025 · Cited by 14
ProspectiveIn VitroModels of Channelopathies and Cardiomyopathies
Kawaguchi, N., Hayama, E., Furutani, Y., & Nakanishi, T. (2012) · Stem Cells International · doi:10.1155/2012/439219 · Cited by 14
Smooth muscle cells largely develop independently of functional hemogenic endothelium
Stefańska, M., Costa, G., Lie‐A‐Ling, M., Kouskoff, V., & Lacaud, G. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.10.009 · Cited by 14
Sequiera, G. L., Mehta, A. K., Ooi, T. H., & SHIM, W. S. N. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.10.020 · Cited by 14
Identification of a coronary stem cell in the human heart
Leri, A., Hosoda, T., Kajstura, J., Anversa, P., & Rota, M. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0769-8 · Cited by 14
“The endocardium and a population of cells in the myocardium originate from a pool of flk-1-positive cells, suggesting that endothelial and myocardial lineages develop, at least in part, from a common progenitor [18].”
BackgroundTan, Y., Han, P., Gu, Q., Chen, G., Wang, L., Ma, R.-Y., Wu, J., Feng, C., Zhang, Y., Wang, L., et al. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2381 · Cited by 14
“Moreover, the cost of a large-scale hESC-CM production using chemically undefined medium consisting of animal-derived components is very high (He et al., 2003; Burridge et al., 2007; Yang et al., 2008; Burridge et al., 2011).”
BackgroundOf form and function: Early cardiac morphogenesis across classical and emerging model systems
Shewale, B., & Dubois, N. C. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.04.025 · Cited by 16
Heart in a Dish: From Traditional 2D Differentiation Protocols to Cardiac Organoids
Ramírez-Calderón, G., Colombo, G., Hernandez-Bautista, C. A., Astro, V., & Adamo, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.855966 · Cited by 15
Cianflone, E., Scalise, M., Marino, F., Salerno, L., Salerno, N., Urbanek, K., & Torella, D. (2022) · Clinical Science · doi:10.1042/cs20220391 · Cited by 14
Kim, B., Lee, Y., Kim, K., Kim, Y.-H., Jung, M.-S., Ha, S.-J., Kang, H., Jung, S.-E., Kim, B.-G., Choi, Y.-R., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2208 · Cited by 14
The proliferation study of hips cell-derived neuronal progenitors on poly-caprolactone scaffold.
Havasi, P., Soleimani, M., Morovvati, H., Bakhshandeh, B., & Nabiuni, M. (2014) · PubMed Central · Cited by 14
Odedra, D., Chiu, L. L. Y., Reis, L. A., Rask, F., Chiang, K., & Radisic, M. (2010) · Springer eBooks · doi:10.1007/978-3-7091-0385-2_15 · Cited by 14
Strategies for replacing myocytes with induced pluripotent stem in clinical protocols
Hattori, F., & Fukuda, K. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2011.09.003 · Cited by 14
“We hypothesized that each cardiogenic protocol might be effective only for a specific PS cell epigenetic state and that this strict requirement could explain how so many different cardiogenic protocols can achieve similar cardiomyocyte differentiation states [48].”
BackgroundNavigating the labyrinth of cardiac regeneration
Lambers, E., & Kume, T. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24397 · Cited by 14
“Induction and inhibition of Wnt-BCatenin signaling pathways and induction of Activin/Nodal/ TGFb, BMP, FGF, and noncanonical Wnt signaling pathways at various stages of cardiac differentiation can increase cardiomyocyte production up to 50% (Laflamme et al., 2007; Yang et al., 2008; Paige et al., 2010; Kattman et al.,…”
BackgroundCardiac Stem Cell Therapy: Stemness or Commitment?
Mehta, A. K., & SHIM, W. S. N. (2013) · Cell Transplantation · doi:10.3727/096368912x653282 · Cited by 15
“Kinase insert domain receptor/fetal liver kinase (flk1/KDR)/ ckit cells selected on days 5–6 of differentiation when plated as monolayer gave rise to 57% cTnI-positive cells (125).”
BackgroundInfluentialTCM visualizes trajectories and cell populations from single cell data
Gong, W., Kwak, I., Koyano‐Nakagawa, N., Pan, W., & Garry, D. J. (2018) · Nature Communications · doi:10.1038/s41467-018-05112-9 · Cited by 14
Stem Cell-Based Therapeutic Approaches to Restore Sensorineural Hearing Loss in Mammals
Waqas, M., Us-Salam, I., Bibi, Z., Wang, Y., Li, H., Zhu, Z., & He, S. (2020) · Neural Plasticity · doi:10.1155/2020/8829660 · Cited by 17
Embryonic stem cells as a model for cardiac development and disease
Evans, T. (2008) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2009.03.004 · Cited by 15
Hudson, J. E., & Zimmermann, W. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.06.011 · Cited by 14
Micropatterned Organoids Enable Modeling of the Earliest Stages of Human Cardiac VascularizationPreprint
Abilez, O. J., Yang, H., Tian, L., Wilson, K. D., Lyall, E. H., Shen, M., Bhoi, R., Zhuge, Y., Jia, F., Wo, H.-T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.08.499233 · Cited by 15
(2012) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.0803013 · Cited by 13
Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones
Frank, E., Cailleret, M., Nelep, C., Fragner, P., Polentes, J., Herardot, E., Kassar, L. E., Giraud-Triboult, K., Monville, C., & M’Barek, K. B. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03327-2 · Cited by 13
“A variety of differentiation protocols from hPSCs in vitro were already developed to generate different adult cell types such as retinal pigment epithelial cells [20], photoreceptors [10], keratinocytes [13] or cardiomyocytes [29].”
BackgroundETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment
Steimle, J. D., Kim, C., Rowton, M., Nadadur, R. D., Wang, Z., Stocker, M., Hoffmann, A. D., Hanson, E., Kweon, J., Sinha, T., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112665 · Cited by 13
Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction
Fiorino, E., Rossin, D., Vanni, R., Aubry, M., Giachino, C., & Rastaldo, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111747 · Cited by 14
Stage-Specific Cardiomyocyte Differentiation Method for H7 and H9 Human Embryonic Stem Cells
Sa, S., & McCloskey, K. E. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9403-6 · Cited by 13
Huang, J., Zhang, M., Zhang, P., He, L., Ouyang, K., & Yang, H. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9512-9 · Cited by 13
Probing early heart development to instruct stem cell differentiation strategies
Calderon, D., Bardot, E., & Dubois, N. C. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24441 · Cited by 14
“Within just a few years, the generation of human PSC-derived cardiomyocytes (hPSC-CMs) has evolved from the initial inefficient serum-based, proof-of-principle differentiation protocols to today’s robust strategies that yield nearly pure cardiomyocyte cultures (Kehat et al., 2001; Yang et al., 2008; Kattman et al., 20…”
BackgroundInfluentialDirect Reprogramming of Cardiac Fibroblasts to Repair the Injured Heart
Adams, E., McCloy, R., Jordan, A., Falconer, K., & Dykes, I. M. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8070072 · Cited by 14
“It was now possible, in theory at least, to take a skin biopsy from a patient and use this to generate an induced pluripotent stem cell (iPSC), which could then be differentiated in vitro into cardiovascular cell types using growth factors present in the embryo such as Nodal/Activin, FGF2 and BMP4 [77] (Figure 2).”
BackgroundStem Cells for Cardiac Regeneration by Cell Therapy and Myocardial Tissue Engineering
Wu, J., Zeng, F., Weisel, R. D., & Li, R. (2009) · Springer eBooks · doi:10.1007/10_2008_37 · Cited by 13
Differentiation of Human Embryonic Stem Cells to Cardiomyocytes on Microcarrier Cultures
Ting, S., Lecina, M., Reuveny, S., & Oh, S. (2012) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc01d07s21 · Cited by 13
Craft, A. M., Krisky, D. M., Wechuck, J., Lobenhofer, E. K., Jiang, Y., Wolfe, D. P., & Glorioso, J. C. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0417 · Cited by 14
Systematic approaches to dissect biological processes in stem cells by image‐based screening
Erdmann, G., Volz, C., & Boutros, M. (2012) · Biotechnology Journal · doi:10.1002/biot.201200117 · Cited by 14
Ishida, M., El-Mounayri, O., Kattman, S. J., Zandstra, P. W., Sakamoto, H., Ogawa, M., Keller, G. M., & Husain, M. (2011) · Circulation Research · doi:10.1161/circresaha.111.259499 · Cited by 14
Self-citationDifferentiation of human ES cell line KIND-2 to yield tripotent cardiovascular progenitors
Pawani, H., Nagvenkar, P. V., Pethe, P. S., & Bhartiya, D. (2013) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-012-9558-0 · Cited by 13
A molecular roadmap of definitive erythropoiesis from human induced pluripotent stem cells
Razaq, M. A., Taylor, S., Roberts, D. J., & Carpenter, L. (2017) · British Journal of Haematology · doi:10.1111/bjh.14491 · Cited by 15
“Most notably, expression of CD34 and KDR is elevated in EryPs, further suggesting their haemangioblastic origin (Yang et al, 2008); globins HBZ and HBE are differentially up-regulated and indicative of an embryonic status (Palis & Yoder, 2001; Baron, 2003), whilst LIN28A is also elevated and…”
BackgroundMeng, Y., Liu, Y., Dakou, E., Gutierrez, G. J., & Leyns, L. (2020) · Development Growth & Differentiation · doi:10.1111/dgd.12659 · Cited by 13
“Kdr and Tbx5 were investigated as cardiovascular progenitor and cardiac precursor markers (Bruneau et al., 2001; Yang et al., 2008), while Myl7 was used to evaluate the maturation of cardiomyocytes (Yamashita et al., 2005).”
MethodCardiac specification during gastrulation – The Yellow Brick Road leading to Tinman
Stutt, N., Song, M., Wilson, M. D., & Scott, I. C. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.11.011 · Cited by 14
Zhao, Y., Godier-Furnémont, A., Bax, N. A. M., Bouten, C. V. C., Brown, L. M., Fine, B. M., & Vunjak‐Novakovic, G. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.02.003 · Cited by 13
“pelleted, and resuspended in basic media [64].”
MethodPark, S., Bae, D., Moon, S., & Chung, H. (2013) · Cardiology · doi:10.1159/000346390 · Cited by 13
Miwa, T., Idiris, A., & Kumagai, H. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.04.008 · Cited by 13
“To combine the high-density spheroid formation and cultivation method of hiPSCs using EZSPHERE vessels with Yang's well-known protocol for embryonic body (EB)/spheroid-based cardiac differentiation [4], 3 106 single cell, dissociated hiPSCs (of the 253G1 cell line [14]) were seeded into a standard 100 mm EZSPHERE dish…”
MethodWang, Z., Nakamura, K., Jinnin, M., Kudo, H., Goto, M., Era, T., Etoh-Kira, T., Nakashima, T., Fukushima, S., & Ihn, H. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.08.002 · Cited by 15
Therapeutic potential of perivascular cells from human pluripotent stem cells
Dar, A., & Itskovitz‐Eldor, J. (2013) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1698 · Cited by 12
“The latter include endothelial cells and a-SMA+ SMCs for further use in research and regenerative animal models (Gerecht-Nir et al., 2003; Ferreira et al., 2007; Yang et al., 2008; Lu et al., 2009; Bu et al., 2009; Vo et al., 2010; Vazão et al., 2011; Wang et al., 2012; Dar et al., 2012).”
BackgroundTompkins, J. D., & Riggs, A. D. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1340-0 · Cited by 12
“However, the molecular details that govern this pathway, especially CPs spontaneous transition into beating CMs, require significantly more investigation to fully exploit puripotent-CM’s in cardiac regeneration (Naito et al., 2006; Ueno et al., 2007; Yang et al., 2008; Rajala et al., 2011).”
BackgroundMeasuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes
Bourque, K., Hawey, C., Jones-Tabah, J., Pétrin, D., Martin, R., Sun, Y., & Hébert, T. E. (2021) · Methods · doi:10.1016/j.ymeth.2021.12.006 · Cited by 13
SWI/SNF in cardiac progenitor cell differentiation
Lei, I., Liu, L., Sham, M. H., & Wang, Z. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24570 · Cited by 14
“CPCs or CPC‐like cells have also been identified in cardiac neural crest, epicardium, sinus venosus, as well as in adult heart [Beltrami et al., 2003; Cai et al., 2003; Oh et al., 2003; Kattman et al., 2006; Moretti et al., 2006; Wu et al., 2006; Yang et al., 2008; Blin et al., 2010].”
BackgroundPeptidomimetic small-molecule compounds promoting cardiogenesis of stem cells
Oh, S., Lee, J. B., Kim, B., Jeon, S., Kim, M., Nam, K., Ha, J.-R., Bhatia, M., Oh, G. T., & Kim, D.-Y. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-1115-6 · Cited by 12
TGFβ1 inhibits lymphatic endothelial cell differentiation from mouse embryonic stem cells
Vittet, D., Merdzhanova, G., Prandini, M., Feige, J., & Bailly, S. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24063 · Cited by 12
“The detection of Prox-1 in the LYVE-1negative cell population is consistent with its known expression in cells of the cardiac lineage in the developing heart, which also originates from the differentiation of Flk1-positive precursors (Kattman et al., 2006; Yang et al., 2008).”
BackgroundCardiac Progenitor Cells and their Therapeutic Application for Cardiac Repair
Cyganek, L. (2013) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.s11-008 · Cited by 15
De Novo Human Cardiac Myocytes for Medical Research: Promises and Challenges
Hamel, V., Cheng, K., Liao, S., Lu, A., Zheng, Y., Chen, Y., Xie, Y., & Liang, W. (2017) · Stem Cells International · doi:10.1155/2017/4528941 · Cited by 13
Morita, Y., Kishino, Y., Fukuda, K., & Tohyama, S. (2022) · Cell Proliferation · doi:10.1111/cpr.13248 · Cited by 14
Tissue-Derived Stem and Progenitor Cells
Tesche, L. J., & Gerber, D. A. (2009) · Stem Cells International · doi:10.4061/2010/824876 · Cited by 13
Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends.
Pawani, H., & Bhartiya, D. (2013) · PubMed Central · Cited by 19
Cao, N., He, L., & Yang, H. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_119 · Cited by 12
Hwang, G. H., Park, S. M., Han, H. J., Kim, J., Yun, S. P., Ryu, J. M., Lee, H. J., Chang, W., Lee, S., Choi, J., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25783 · Cited by 12
“…conditions, defined sizes of EB generation, and optimization of growth factors to regulate the cardiogenic signaling pathway to improve efficiency or reproducibility of cardiac differentiation (Elliott et al., 2011; Kehat et al., 2001; Kattman et al., 2011; Stevens, 1960; Yang et al., 2008).”
BackgroundNoort, W. A., Sluijter, J. P. G., Goumans, M., Chamuleau, S. A. J., & Doevendans, P. A. (2009) · Pediatric Cardiology · doi:10.1007/s00246-008-9370-5 · Cited by 13
“The cells were identified by (1) the ability of cells to efflux the DNA-binding dye Hoechst 33342 (side population [SP]) [26, 30, 64, 95]; (2) the presence of specific antigens on the cell surface, e.g., c-kit, Sca-1, and KDR [13, 27, 42, 47, 60, 90 ]; (3) gene expression of certain transcription factors including Isl…”
BackgroundCardiovascular stem cells in regenerative medicine: ready for prime time?
Liu, Y., Karra, R., & Wu, S. M. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.12.003 · Cited by 12
“The isolation of human ESC-derived cardiac progenitor cells has also been described recently [45].”
BackgroundAl-attar, R., Jargstorf, J., Romagnuolo, R., Jouni, M., Alibhai, F. J., Lampe, P. D., Solan, J. L., & Laflamme, M. A. (2024) · Biomolecules · doi:10.3390/biom14010061 · Cited by 11
Solomon, A. D., Dabral, S., Brajesh, R. G., Day, B. W., Juric, M., Zielonka, J., Bosnjak, Z. J., & Pant, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093966 · Cited by 13
“For example, embryonic stem cells (ESCs) have been widely explored with a determined aim to generate functional cardiomyocytes (CMs) and rejuvenate the damaged myocardium [12,13].”
Leung, H. W., Moerkamp, A. T., Padmanabhan, J., Ng, S., Goumans, M., & Choo, A. B. H. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.016 · Cited by 11
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.